Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Somatostatin receptor imaging with [68Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinomaLiang Zhao, Yizhen Pang, Yuhuan Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2021
68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancerLiang Zhao, Shanyu Chen, Sijia Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2025
FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic managementWei Guo, Weizhi Xu, Tinghua Meng, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacyJianhao Chen, Yangfan Zhou, Yizhen Pang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2024
Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinomaJianhao Chen, Yizhen Pang, Xiyi Liao, et al.
ACS Applied Materials & Interfaces|April 4, 2025
Molecular Imaging of B7-H3-Targeting Bispecific T Cell-Engaging Antibody MGD009 in Glioblastoma ModelsPeifei Liu, Haizhen Ding, Shubing Jia, et al.
Molecular Pharmaceutics|August 2, 2022
Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor EfficacyLiang Zhao, Jianhao Chen, Yizhen Pang, et al.
European Radiology|August 17, 2022
Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective studyHaojun Chen, Yizhen Pang, Junpeng Li, et al.
Theranostics|December 4, 2024
68Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with 18F-FDG PET/CT and contrast-enhanced MRIDan Ruan, Jianping Sun, Chengkun Han, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2020
Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CTWei Guo, Yizhen Pang, Lanlin Yao, et al.
Pageof 8